Cargando…
Stimulus-responsive self-assembled prodrugs in cancer therapy
Small-molecule prodrugs have become the main toolbox to improve the unfavorable physicochemical properties of potential therapeutic compounds in contemporary anti-cancer drug development. Many approved small-molecule prodrugs, however, still face key challenges in their pharmacokinetic (PK) and phar...
Autores principales: | Dong, Xiao, Brahma, Rajeev K., Fang, Chao, Yao, Shao Q. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006903/ https://www.ncbi.nlm.nih.gov/pubmed/35509461 http://dx.doi.org/10.1039/d2sc01003h |
Ejemplares similares
-
The evolution of nucleosidic analogues: self-assembly of prodrugs into nanoparticles for cancer drug delivery
por: Baroud, Milad, et al.
Publicado: (2021) -
Self-assembly of diclofenac prodrug into nanomicelles for enhancing the anti-inflammatory activity
por: Assali, Mohyeddin, et al.
Publicado: (2021) -
Disulfide based prodrugs for cancer therapy
por: Wang, Qiang, et al.
Publicado: (2020) -
Targeted Prodrug-Based Self-Assembled Nanoparticles for Cancer Therapy
por: Wang, Weiwei, et al.
Publicado: (2020) -
Self-assembly nanoplatform of platinum (Ⅳ) prodrug for enhanced ovarian cancer therapy
por: Ma, Xiao, et al.
Publicado: (2023)